RVP Retractable Technologies, Inc., A Contract from DHHS to supply swine flu vaccinces
Retractable Technologies, Inc.
Retractable Technologies, Inc. was chosen by the Department of Health and Human Services to supply the syringes to be used in the up coming H1N1 swine flu mass vaccinations. The contract was awarded to Retractable Technologies, Inc., and is expected to run through March 2010 and inoculate 195 million Americans.
StockEinstein.com offers free trading alerts on stocks about to run. To sign up for our free alert service please click here www.stockeinstein.com or scroll to bottom of this page to sign up.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety medical products for the healthcare industry in the United States and internationally. The company offers VanishPoint safety needle products to prevent needlestick injuries and reuse. Its products include 1cc tuberculin, insulin, and allergy antigen VanishPoint syringes; 0.5cc, 3cc, 5cc, and 10cc VanishPoint syringes; the VanishPoint blood collection tube holder; autodisable syringe and the VanishPoint IV safety catheter; and a small diameter tube adapter. The company's products also include Patient Safe syringe, which reduces the risk of infection resulting from IV contamination, as well as dental syringe, winged IV sets, and an autodisable syringe. It markets its products to healthcare providers, which include acute care hospitals, alternate care facilities, doctors offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors. Retractable Technologies, Inc. was founded in 1994 and is headquartered in Little Elm, Texas.
About StockEinstein
StockEinstein.com uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
Thank you for your interest in Findit News. A member of the Findit News team will contact you soon to show you how you can take your marketing to the next level with press releases on Findit.
